A Phase 3 interventional study of Lowering the dialysate sodium in Hemodialysis, sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-06.
Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Phase 3, Interventional, and Treatment
Patients currently receiving hemodialysis will be randomized to receive 1 of 3 dialysate sodium prescriptions. The effects on blood pressure, interdialytic weight gain, thirst, and intradialytic symptoms will be assessed.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's is the lead sponsor of 327 studies on the registry; 132 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
standard dialysate Na 140 mEq/L
Other: Lowering the dialysate sodium
dialysate sodium equal to patient's predialysis serum Na
Other: Lowering the dialysate sodium
dialysate sodium lower than patient's predialysis plasma sodium
Other: Lowering the dialysate sodium
Please see above
Ambulatory blood pressure
Ambulatory blood pressure to be taken over 24 hours at 4 week intervals throughout the study
Time frame: 3 months
thirst
Time frame: 3 months
QOL Scores (KDQOL, mins to recovery)
Time frame: 3 months
intradialytic hypotension rate, intradialytic symptoms
Time frame: 3 months
mechanistic outcomes: interdialytic weight gain, extracellular fluid water, sodium ionic mass balance
Time frame: 3 months
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's →